178 related articles for article (PubMed ID: 9469691)
1. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
[TBL] [Abstract][Full Text] [Related]
3. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
4. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
[TBL] [Abstract][Full Text] [Related]
5. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
Chan JC
Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
[TBL] [Abstract][Full Text] [Related]
6. Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.
Kitrenos JG; Rotella DL; Nakasato S
Adv Ther; 1995; 12(1):30-43. PubMed ID: 10150321
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
Lawrenz CA; Cole P; Theodorou A; Cook RL; Bermann L
Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
[TBL] [Abstract][Full Text] [Related]
9. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
Weigelt JA
Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
McKinnon PS; Paladino JA; Grayson ML; Gibbons GW; Karchmer AW
Clin Infect Dis; 1997 Jan; 24(1):57-63. PubMed ID: 8994756
[TBL] [Abstract][Full Text] [Related]
11. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Falagas ME; Barefoot L; Griffith J; Ruthazar R; Snydman DR
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873
[TBL] [Abstract][Full Text] [Related]
12. [Acute bacterial salpingitis. The importance of residual inflammation. A comparative study with celioscopic control of 2 antibiotic protocols: sulbactam-ampicillin versus cefoxitin].
Le Bouedec G; Pouly JL; Mage G; Canis M; Wattiez A; Abbas Muhktar B; Bruhat MA
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):765-72. PubMed ID: 2147930
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
Infection; 1990; 18(1):41-7. PubMed ID: 2179137
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Stromberg BV; Reines HD; Hunt P
Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
[TBL] [Abstract][Full Text] [Related]
15. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
16. Ampicillin/sulbactam vs. clindamycin/gentamicin in the treatment of postpartum endometritis.
Gall S; Koukol DH
J Reprod Med; 1996 Aug; 41(8):575-80. PubMed ID: 8866384
[TBL] [Abstract][Full Text] [Related]
17. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
Madan AK
Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic penetration of experimental intra-abdominal abscesses.
Galandiuk S; Lamos J; Montgomery W; Young S; Polk HC
Am Surg; 1995 Jun; 61(6):521-5. PubMed ID: 7762902
[TBL] [Abstract][Full Text] [Related]
20. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
Lode H; Springsklee M
Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
